Please login to the form below

Not currently logged in
Email:
Password:

CNS

This page shows the latest CNS news and features for those working in and with pharma, biotech and healthcare.

Celgene bulks up pipeline again with $2.1bn Prothena deal

Celgene bulks up pipeline again with $2.1bn Prothena deal

It’s also been working with Evotec on therapies for neurodegenerative disorders using the German biotech’s stem cell screening platform, and has accelerated its R&D efforts in CNS after

Latest news

More from news
Approximately 4 fully matching, plus 161 partially matching documents found.

Latest Intelligence

  • A quest for innovative solutions A quest for innovative solutions

    PRISM has matured into an artery of new opportunities such as its collaboration on RADAR-CNS (Remote Assessment of Disease and Relapse - Central Nervous System), an initiative that aims to develop

  • The good, the bad and the ugly The good, the bad and the ugly

    Pfizer has large sales in CNS - $8.5bn in 2017. The majority come through Lyrica ($5bn). ... In Europe, a patent dispute over Lyrica became arguably the biggest CNS story in recent years.

  • Pharma deals continue to slide Pharma deals continue to slide

    1, 410 (upfront 80). WuXi Biologics and Gloria Pharma (CN). Arcus Biosciences (US). ... 163. Mologen (DE). iPharma (CN). Binding term sheet for licensing and co-development.

  • Deal Watch - May 2017 Deal Watch - May 2017

    Peptidream (CN). Janssen (US). Licence. Peptide discovery platform. Up to 1, 150.

  • Deal Watch September 2016 Deal Watch September 2016

    210. Ligand / Seelos. Licence. 4 programmes including aplindore for CNS disorders.

More from intelligence
Approximately 0 fully matching, plus 38 partially matching documents found.

Latest appointments

  • Damien McDevitt moves from GSK to Acadia Pharmaceuticals Damien McDevitt moves from GSK to Acadia Pharmaceuticals

    At Acadia, which focuses on the development and commercialisation of medicines for central nervous system (CNS) disorders, McDevitt will report to the company’s president and chief executive officer Steve Davis. ... This expertise, combined with his

  • Ron Menezes joins Almirall’s Aqua Pharmaceuticals Ron Menezes joins Almirall’s Aqua Pharmaceuticals

    Menezes joins the group from Depomed Pharmaceuticals, where he served as vice president of sales and sales operations, pain and CNS.

  • emotive boosts its client services team emotive boosts its client services team

    Joining as a senior account director, Andy Parry has 9 years’experience in healthcare communications and has worked on global brands in CNS, infectious diseases, respiratory and rare disease.

  • Axon bolsters team with new PR Director hire Axon bolsters team with new PR Director hire

    During her career, Smiddy has led local, regional and international programmes to support pharmaceutical products in numerous therapeutic fields including cardiology, immunology, CNS and oncology.

  • Therachon strengthens management team Therachon strengthens management team

    He most recently served as a senior director at Lundbeck, leading the Danish firm's global biologics programme to treat CNS diseases, and before this held senior roles at Amplimmune and

More from appointments
Approximately 0 fully matching, plus 24 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 10 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Dovetail

Transforming healthcare through effective collaboration. Making work to feel proud of. www.dovetailstrategies.com...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics